EP 0755268 A1 19970129 - COMPOSITIONS AND METHODS FOR GENE THERAPY TO TREAT DISEASE
Title (en)
COMPOSITIONS AND METHODS FOR GENE THERAPY TO TREAT DISEASE
Title (de)
ZUSAMMENSETZUNGEN UND VERFAHREN ZUR BEHANDLUNG VON ERKRANKUNGEN DURCH GENTHERAPIE
Title (fr)
COMPOSITIONS ET PROCEDES DE THERAPIE GENIQUE POUR TRAITER DES MALADIES
Publication
Application
Priority
- US 9504397 W 19950410
- US 22584094 A 19940411
Abstract (en)
[origin: WO9527512A2] Method of gene therapy for the treatment of a variety of genetic defects or diseases comprising the steps of either introducing transformed cells into an organism such as a human or the in vivo transformation of cells. The transformed cells contain a nucleic acid vector which will produce the protein necessary to correct the deficiency or disease. Examples of diseases which can be treated this way include diabetes mellitus, Parkinson's disease, cardiovascular disease, hypercholesterolemia, hypertension, anemia, thrombosis, growth disorders, metabolic disorders such as PKU and serum protein disorders, such as hemophilia A.
IPC 1-7
IPC 8 full level
A61K 38/17 (2006.01); A61K 38/18 (2006.01); A61K 38/22 (2006.01); A61K 38/27 (2006.01); A61K 38/28 (2006.01); A61K 38/34 (2006.01); A61K 38/36 (2006.01); A61K 38/37 (2006.01); A61K 38/44 (2006.01); A61K 38/46 (2006.01); A61K 38/48 (2006.01); A61K 38/57 (2006.01); A61K 48/00 (2006.01); C07K 14/62 (2006.01); A61K 38/00 (2006.01)
CPC (source: EP)
A61K 38/1709 (2013.01); A61K 38/177 (2013.01); A61K 38/1816 (2013.01); A61K 38/2242 (2013.01); A61K 38/27 (2013.01); A61K 38/34 (2013.01); A61K 38/37 (2013.01); A61K 38/38 (2013.01); A61K 38/44 (2013.01); A61K 38/465 (2013.01); A61K 38/47 (2013.01); A61K 48/00 (2013.01); C07K 14/62 (2013.01); A61K 38/00 (2013.01)
Designated contracting state (EPC)
AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 9527512 A2 19951019; WO 9527512 A3 19951221; AU 2283495 A 19951030; AU 695618 B2 19980820; CA 2188675 A1 19951019; EP 0755268 A1 19970129
DOCDB simple family (application)
US 9504397 W 19950410; AU 2283495 A 19950410; CA 2188675 A 19950410; EP 95916281 A 19950410